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12-month prevalence of asthma among adults in Germany
Abstract
Asthma is a chronic inflammatory disease of the airways affecting people of all ages. The disease is characterised 
by a variable narrowing of the bronchia, which may be accompanied by symptoms such as wheezing or shortness 
of breath. In GEDA 2014/2015-EHIS, 6.2% of respondents aged 18 years or older with complete information on the 
respective indicator (n=22,671) reported having had asthma during the past 12 months. The 12-month prevalence 
among women (7.1%) is higher than among men (5.4%). Overall, women and men with a low level of education 
more often reported having had asthma than those with a higher level of education. In analyses stratified by age 
and gender, differences in asthma prevalence with regard to educational level are evident among women under 30 
years of age. In a comparison of federal states, the prevalence of asthma ranges from 3.0% to 9.7% among women 
and from 2.9% to 7.0% among men.
  ASTHMA · PREVALENCE · ADULTS · HEALTH MONITORING · GERMANY
Introduction
According to the World Health Organization (WHO), 
asthma is one of the most common chronic diseases 
affecting around 235 million people globally [1]. Asthma 
can occur among people of all ages [2-5]. The disease is 
characterised by chronic inflammation and increased 
sensitivity (hyperresponsiveness) of the airways to 
diverse inhaled stimuli [5, 6]. Asthma patients moreover 
suffer from variable narrowing of the bronchia (airway 
obstruction) accompanied by symptoms such as wheez-
ing, shortness of breath, chest tightness or coughing 
which vary over time and in intensity [5, 6]. Some patients 
with mild asthma may experience periods when they are 
completely free of symptoms [5, 7]. In particular, in case 
of an asthma onset in childhood, remission of symp-
toms during puberty is frequently observed [4, 8]. 
Asthma is a heterogeneous disease which results 
from different underlying disease mechanisms [5, 9]. 
Allergic asthma and also other forms of non-allergic 
asthma are marked by a characteristic type of inflamma-
tion [5, 9]. This (TH2) type of inflammation is indicated 
by elevated concentrations of specific immune cells 
(eosinophils) in the airway mucosa and in the blood 
(eosinophilic asthma) [5, 6, 9]. Further, mainly adult-on-
set, forms of asthma exist, where such an overproduc-
tion of eosinophils cannot be observed (non-eosinophilic 
asthma) [5, 6, 9]. It is important to distinguish between 
eosinophilic and non-eosinophilic asthma, when treat-
ing patients with severe asthma [5, 6, 9].
A family history of asthma or of certain allergies (such 
as hay fever) is an important predisposing factor [5, 
10-12]. Asthma thereby results from complex interactions 
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for deviations within the sample from the German pop-
ulation structure (as of 31 December 2014) with regard 
to gender, age, district type and education. The district 
type reflects the degree of urbanisation and corresponds 
to the regional distribution in Germany. The Internation-
al Standard Classification of Education (ISCED) was used 
to classify the responses provided on educational level 
[14]. Lange et al. [15] set out the details of the methodol-
ogy applied in the GEDA 2014/2015-EHIS study includ-
ing the method used to calculate the weighting factor 
and an assessment of the response rate. Background 
information on the GEDA 2014/15-EHIS is also provided 
in the article German Health Update: New data for Ger-
many and Europe in Issue 1/2017 of the Journal of Health 
Monitoring.
Results and discussion
6.2% of adults aged 18 years or older reported having 
had asthma during the past 12 months. Overall, women 
(7.1%) show a higher 12-month prevalence of asthma 
than men (5.4%) (Table 1). Asthma prevalence is high-
est in the age group 45 to 64 years among men while it 
remains on a similar level across all age groups among 
women. Overall, women and men with a low level of 
education more frequently reported to have had asthma 
than those with a medium or high level of education 
(7.7% vs. 5.9% and 5.7%). In analyses stratified by age 
and gender, these differences with regard to education-
al level are evident among women aged 18 to 29 years 
(Table 1). Prevalence estimates vary considerably between 
federal states ranging from 3.0% in Mecklenburg West-
ern-Pomerania to 9.7% in Brandenburg among women 
between genetic and environmental factors [2, 5, 12]. 
Early childhood yet also prenatal influences are highly 
relevant in the induction of the disease [2, 5, 12]. Infec-
tions, exposure to microbes, pollutants and allergens, 
but also diet or psychosocial factors may contribute to 
asthma development [2, 5, 12]. Furthermore, occupa-
tional exposures have been identified (e.g., allergens 
such as flour and cow hair or chemical irritants such as 
disinfectants and agents used by hairstylists) which can 
induce or aggravate asthma in adulthood [2, 13]. Provid-
ing appropriate medical care to asthma patients is highly 
important to prevent episodes in which the disease wors-
ens acutely and which can require emergency care or 
lead to premature mortality [5]. In the majority of patients, 
however, adequate treatment can minimise the symp-
toms of asthma and associated limitations in usual activ-
ities [5].
Indicator 
In the GEDA 2014/2015-EHIS survey, the prevalence of 
asthma during the past 12 months was assessed by using 
a self-administered paper-based or online questionnaire. 
Respondents were asked, ‘During the past 12 months, 
have you had any of the following diseases or condi-
tions?’ This question was followed by a list of conditions 
that also contained ‘asthma (allergic asthma included)’. 
24,016 adults aged 18 years or older (13,144 women and 
10,872 men) participated in GEDA 2014/2015-EHIS. 1,345 
respondents (696 women and 649 men) with missing 
information on the indicator on self-assessed asthma 
were excluded from the current analysis. The calculations 
were carried out using a weighting factor that corrects 
GEDA 2014/2015-EHIS
Data holder: Robert Koch Institute
Aims: To provide reliable informa tion 
about the population’s health status, 
health-related behaviour and health care  
in Germany, with the possibility of a  
European comparison 
Method: Questionnaires completed on 
paper or online
Population: People aged 18 years and above 
with permanent residency in Germany
Sampling: Registry office sample; randomly 
selected individuals from 301 communities 
in Germany were invited to participate
Participants: 24,016 people (13,144 women; 
10,872 men)
Response rate: 26.9%
Study period: November 2014 - July 2015
Data protection: This study was undertaken 
in strict accordance with the data protection 
regulations set out in the German Federal 
Data Protection Act and was approved by 
the German Federal Commissioner for Data 
Protection and Freedom of Information.  
Participation in the study was voluntary. 
The participants were fully informed about 
the study’s aims and content, and about 
data protection. All participants provided 
written informed consent.
 
More information in German is available at 
www.geda-studie.de
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Australia and the USA [17]. Results from longitudinal 
studies moreover point to an increased asthma risk for 
women relative to men, whereby this difference is already 
evident in adolescence (see also the Focus article on 
respiratory diseases in this issue) [17, 18]. Regarding 
socio-economic differences, the surveys available 
revealed heterogeneous results. Overall, in the majority 
of studies, however, a higher prevalence of asthma is 
related to lower social status [19]. A comparison of GEDA 
2014/2015-EHIS results by gender or socio-economic 
criteria needs to consider further aspects. Differences 
in the way patients perceive symptoms, seek medical 
care or adhere to treatment recommendations - and 
and from 2.9% in Saxony-Anhalt to 7.0% in North Rhine 
Westphalia and Saarland among men (Figure 1). 
The current results on the 12-month prevalence of 
asthma in GEDA 2014/2015-EHIS are consistent with 
results of the German national telephone health inter-
view survey German Health Update (GEDA 2012) con-
ducted by the Robert Koch Institute in 2012 [16]. This 
applies both to the overall prevalence of asthma among 
adults (6.2% vs. 6.3% in 2012) and to estimates by gen-
der (women: 7.1% vs. 7.5%; men: 5.4% vs. 5.0%) [16]. 
Comparable differences between genders (an overall 1.3 
to 1.5-fold higher prevalence of asthma among women) 
were observed in epidemiological surveys in Europe, 
Women % (95% CI)
Women total 7.1 (6.5-7.7)
18-29 Years 7.8 (6.4-9.6)
Low education 13.3 (8.9-19.4)
Medium education 6.5 (5.1-8.2)
High education 5.2 (3.3-8.2)
30-44 Years 6.4 (5.4-7.6)
Low education 8.5 (5.4-13.1)
Medium education 6.1 (4.8-7.6)
High education 6.2 (4.8-8.0)
45-64 Years 7.1 (6.3-8.0)
Low education 7.0 (5.0-9.6)
Medium education 7.1 (6.1-8.4)
High education 7.2 (5.8-8.8)
≥ 65 Years 7.1 (6.1-8.4)
Low education 7.3 (5.6-9.5)
Medium education 6.7 (5.2-8.5)
High education 6.9 (4.7-10.1)
Total (women and men) 6.2 (5.8-6.7)
Men % (95% CI)
Men total 5.4 (4.8-5.9)
18-29 Years 3.6 (2.7-4.7)
Low education 4.1 (2.1-7.7)
Medium education 2.9 (2.0-4.1)
High education 5.8 (3.5-9.5)
30-44 Years 5.1 (4.1-6.4)
Low education 7.3 (4.1-12.6)
Medium education 4.4 (3.1-6.1)
High education 5.7 (4.0-8.1)
45-64 Years 6.3 (5.4-7.2)
Low education 8.5 (5.8-12.3)
Medium education 6.6 (5.3-8.1)
High education 5.0 (4.0-6.2)
≥ 65 Years 5.5 (4.5-6.7)
Low education 8.0 (5.3-11.9)
Medium education 5.3 (3.9-7.0)
High education 4.8 (3.4-6.7)
Total (women and men) 6.2 (5.8-6.7)
CI=Confidence interval
 * n=51 additional missing values (26 women, 25 men) when stratifying by educational level
Table 1 
12-month prevalence of asthma by gender, 
age and educational level 
(n=12,448  women; n=10,223 men) 
Source: GEDA 2014/2015-EHIS
About 6% of adults reported 
having had asthma during 
the past 12 months.
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sider some change in methods and hence preclude ana- 
lyses of trends in asthma prevalence over time [16, 22-24]. 
In accordance with the regulation on the harmonisation 
of European health reporting, GEDA 2014/2015-EHIS 
used self-reported information on asthma prevalence 
based on the self-assessment of respondents. As in other 
resulting differences in the degree of treatment and 
asthma control - may all affect levels of self-reported 
asthma prevalence [20, 21].
Direct comparisons of prevalence estimates obtained 
from GEDA 2014/2015-EHIS with those obtained from 
previous German national health surveys need to con-







































Confidence intervals in parentheses
Figure 1 
12-month prevalence of asthma 
by gender and federal state 
(n=12,448 women; n=10,223 men) 
Source: GEDA 2014/2015-EHIS 
Women (7.1%) show a higher 
12-month prevalence of 
asthma than men (5.4%).
i
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high [25, 29, 41]. Among adults, however, a further 
increase in prevalence over the course of the last decade 
has nonetheless been recorded in several countries in 
Europe and in the USA [27, 28, 31, 33, 42].
High regional variation in asthma prevalence has 
been observed not only in GEDA 2014/2015-EHIS based 
on analyses stratified by federal state. Using ambulatory 
health care data, a recent study reported considerable 
variation in asthma prevalence at the county level rang-
ing from 2.5% to 7.7% for the total population [43]. Ear-
lier European surveys indicated significant regional dif-
ferences with a high prevalence mainly in the United 
Kingdom and low prevalence in Eastern European 
regions [2, 3, 44, 45]. In line with Europe-wide data for 
adults [2, 46], current asthma prevalence in Germany as 
recorded in GEDA 2014/2015-EHIS is mid-range com-
pared to other countries of the EU. Previous studies 
including a national health survey of adults in Germany 
indicated a lower prevalence of asthma in East than in 
West Germany [47-51]. The German Health Interview and 
Examination Survey for Children and Adolescents 
(KiGGS) 2003-2006, however, which was conducted 
among children and adolescents most of whom were 
born after German reunification, revealed no significant 
differences between East (including Berlin) and West 
Germany [24]. Future investigations on the regional dif-
ferences in asthma prevalence among adults in Germany 
should thus include in-depth analyses that do not only 
stratify by age and birth year, respectively, but also con-
sider the place where respondents were born and raised.
Previously observed temporal and regional differ-
ences in asthma prevalence were related to the develop-
large epidemiological surveys [25-34], all national health 
surveys previously conducted in Germany, starting with 
the German Health Interview and Examination Survey 
1997-1999 (GNHIES98) [16, 22-24], however, collected 
data on self-reported physician-diagnosed asthma. In 
comparison with the currently applied indicator on 
self-assessed asthma, prior results on the prevalence of 
physician-diagnosed asthma may be less prone to mis-
classification [32]. In addition, previous national health 
surveys also assessed the lifetime prevalence of physi-
cian-diagnosed asthma which was consistently higher 
than the recorded 12-month prevalence [16, 22-24]. These 
differences between lifetime and 12-month prevalence 
indicate the varying degrees of disease activity over time 
in individuals with asthma [4, 7, 8]. In some patients, 
symptoms of asthma may resolve, at least for longer 
periods of time [4, 7, 8].
In Germany, an increase in the lifetime prevalence of 
physician-diagnosed asthma was recorded for both gen-
ders among adults (1997-1999 and 2008-2011) as well 
as among children and adolescents (2003-2006 and 
2009-2012) [22-24]. At the same time, an increment in 
the 12-month prevalence was likewise observed; among 
adults this was attributable mainly to an increase in the 
prevalence among women [23, 35]. Interview survey data 
had already indicated a rising prevalence of asthma in 
the 1990s in Germany especially among children [26, 29, 
36-40]. Moreover, an increase in the prevalence of asthma 
was also observed in other parts of the world during the 
second half of the last century [29]. Recent data indicates 
that this trend has come to a halt at least in certain 
regions such as Australia where prevalence is already 
In a comparison of federal 
states, the prevalence of 
asthma ranges from 3.0% to 
9.7% among women and 
from 2.9% to 7.0% among 
men.
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ment of time trends and the geographical distribution 
of several lifestyle and environmental factors [12, 29, 50]. 
In addition, the influence of temporal changes and 
regional differences in degrees of awareness and provi-
sion of care, respectively, was also discussed [27, 29, 43, 
50]. The recently observed changes in asthma prevalence 
over time point to the importance of continuous health 
monitoring based on periodically repeated national 
health surveys using comparable instruments of data 
collection. Besides extending the available database from 
national health interview and examination surveys per-
mitting analyses of trends in the prevalence of physi-
cian-diagnosed asthma, it will be highly important to 
build a reliable database for the analysis of trends in 
self-assessed asthma prevalence using the current indi-
cator in the context of European health interview surveys. 
Moreover, clarifying the underlying causes of regional 
and gender-specific differences in the prevalence of 
asthma remains a key challenge [12]. 
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